Acumen pharmaceuticals to report second quarter 2022 financial results on august 15, 2022

Charlottesville, va. and carmel, ind., aug. 08, 2022 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for alzheimer's disease (ad), today announced that the company will report its financial results for the second quarter 2022 on monday, august 15, 2022. the company will host a conference call and live audio webcast at 4:30 p.m. et to provide a business and financial update.
ABOS Ratings Summary
ABOS Quant Ranking